Vaccine-associated paralytic poliomyelitis in a patient with MHC class II deficiency

Nima Parvaneh1, Shohreh Shahmahmoudi, Hamideh Tabatabai

  • 1Department of Pediatrics, Infectious Disease Research Center, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.

Insights

Vaccine-associated paralytic poliomyelitis (VAPP) is a rare oral polio vaccine complication. A fatal VAPP case in an infant with immune deficiency involved a rare poliovirus recombinant.

Area of Science:

  • Immunology
  • Virology
  • Pediatrics

Background:

  • Vaccine-associated paralytic poliomyelitis (VAPP) is a rare but serious complication associated with the oral polio vaccine (OPV).
  • Major Histocompatibility Complex (MHC) Class II deficiency is a primary immunodeficiency disorder affecting cellular immunity.

Observation:

  • This report details a fatal case of VAPP in an 8-month-old boy diagnosed with MHC Class II deficiency.
  • The patient developed paralytic poliomyelitis following OPV administration.

Findings:

  • The poliovirus isolated from the patient was a Sabin type 2-type 1 recombinant.
  • Genetic analysis revealed a 1.4% divergence in the VP1 gene compared to the Sabin type 2 strain, suggesting potential alterations in viral properties.

Implications:

  • This case highlights the risks of OPV in immunocompromised individuals, particularly those with primary immunodeficiencies.
  • Understanding the characteristics of poliovirus recombinants is crucial for assessing VAPP risk and informing vaccination strategies.

Related Concept Videos

Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Vaccinations01:51

Vaccinations

Overview
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...